The time for cost-effectiveness in the new European Union member states: The development and role of health economics and technology assessment in the mirror of the Hungarian experience

European Journal of Health Economics

Volumn 8, Issue 2, 2007, Pages 83-88

  Gulácsi, László ^a  

^a Institute of Entrepreneurship and Innovation   (Hungary)

Author keywords

Central Europe; Health economic evaluation; Hungary

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; EUROPE; GOVERNMENT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH EDUCATION; HEALTH INSURANCE; HUMAN; HUNGARY; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MORTALITY; NEEDS ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REIMBURSEMENT; RESOURCE ALLOCATION; REVIEW; SAMPLE SIZE;

COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; EUROPEAN UNION; HEALTH CARE COSTS; HEALTH POLICY; HUNGARY; QUALITY-ADJUSTED LIFE YEARS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 34248331756     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-007-0046-5     Document Type: Review

References (23)

1. Drummond, M.F.: Will there ever be a European drug pricing and reimbursement agency? Eur. J. Health Econ. 4, 67-69 (2003)
2. Drummond, M.F., Manca, A., Schulpher, M.: Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int. J. Technol. Assess. Health Care 21(2), 165-172 (2005)
3. Jönsson, B.: Time for a common standard for cost-effectiveness in Europe. Eur. J. Health Econ. 7, 223-224 (2006)
4. Tam, T.Y., Smith, M.D.: Pharmacoeconomic guidelines around the world. ISPOR, CONNECTIONS 10, 4-5 (2004)
5. Boulenger, S., Nixon, J., Drummond, M.F., Ulmann, P., Rice, S., Pouvourville, G.: Can economic evaluations be made more transferable? Eur. J. Health Econ. 6(4), 134-147 (2005)
6. Baltussen, R., Brouwer, W., Niessen, L.: Cost-effectiveness analysis for priority setting in health: penny-wise but pound-foolish. Int. J. Technol. Assess. Health Care 21.4, 532-534 (2005)
7. Polder, J.J., Meerding, W.J., Bonneux, l., van der Maas, P.J.: A cross-national perspective on cost of illness. Eur. J. Health Econ. 50, 223-232 (2005)
8. Kobelt, G.: Health economic issues in rheumatoid arthritis. Scand J Rheumatol 35, 415-425 (2006)
9. Mittendorf, T., Merkesdal, S., Huelsemann, J.L., von der Schulemburg, M., Zeidler, H., Ruof, J.: Implementing standardized cost categories within economic evaluations in musculoskeletal diseases. Eur. J. Health Econ. 4, 43-49 (2003)
10. Donaldson, C., Farrar, S.: Needs assessment: developing an economic approach. Health Policy 25, 95-108 (1993)
11. Cochrane, A.: Effectiveness and efficiency. The Nuffield Provincial Hospital Trust, London (1971)
12. Gulácsi, L., Boncz, I., Drummond, M.: Issues for countries considering introducing the 'fourth hurdle': the case of Hungary. Int. J. Technol. Assess. Health Care 20(2), 1-5 (2004)
13. Kárpáti, K., Brandtmüller, Á., Májer, I., Gulácsi, L.: Rangsorolás az egészségügyben; gyógyszer-támogatási prioritások Magyarországon 2004-ben. Acta Pharm. Hung. 76(4), 191-199 (2006)
14. Klazinga, N.: A better use of existing resources; managing the quality of structure, process and outcome of health care system. J. Int. Bioethique 7(2), 90-93 (1996)
15. Boncz, I.: Financial deficits in the health services of UK and Hungary. Lancet 368, 917-918 (2006)
16. Boncz, I., Dózsa, C.S., Kaló, Z., Nagy, L., Borcsek, B., Brandtmüller, Á., Betlehem, J., Sebestyén, A., Gulácsi, L.: Development of health economics in Hungary between 1990-2006. Eur. J. Health Econ. 7(Suppl 1), 4-6 (2006)
17. Methodological guidelines for conducting economic evaluation of health care interventions in Hungary. Off. J. Minist. Health Soc. Fam. Aff. Bp. 52(11), 1314-1334 (2002)
18. Szende, A., Mogyorosy, Z., Muszbek, N., Nagy, J., Pallos, G., Dózsa, C.S.: Methodological guidelines for conducting economic evaluation of healthcare interventions in Hungary: a Hungarian proposal for methodology standard. Eur. J. Health Econ. 3, 196-206 (2002)
19. Orlewska, E., Mierzejwski, P.: Project of Polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines. Eur. J. Health Econ. 4, 296-303 (2003)
20. Lepp-Gazdag, A., Gulácsi, L., Brandtmüller, Á., Dávid, T. A rheumatoid arthritis megbetegedés és az ellátás jellemzoi Magyarországon. Egészsé gügyi Gazdasági Szemle 40(6):645-657 (2002)
21. Kiss, C.G., Lovei, C., Suto, G., et al.: Prevalence of rheumatoid arthritis in the South-Transdanubian region of Hungary based on a representative survey of 10,000 inhabitants. J. Rheumatol. 32, 1688-1690 (2005)
22. Péntek M., Kobelt G., Czirják L., Szekanecz Z., Poór G., Rojkovich B., Polgár A., Genti G., Kiss C.G., Brodszky V., Májer I., Gulácsi L.: Costs of rheumatoid arthritis in Hungary. J. Rheumatol. (2007) (in press)
23. Buxton, M.: How much are health-care systems prepared to produce a qualy. Eur. J. Health Econ. 6, 285-287 (2005)